EUVIMEDSkopri EUVIMED
Crossref

Letter to the editor Intranasal sufentanil and its emerging clinical Applications: beyond its role in the emergency department

Shailendra Kapoor, MD

Journal of Opioid Management · 2012

DOI: 10.5055/10 ↗

At a glance

Journal article in Journal of Opioid Management, 2012. Written by Shailendra Kapoor and 1 co-authors.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Dear Editor:I read with great interest the recent article by Stephen et al.(For instance, in a recent study, intranasal sufentanil was rated as a better alternative than prestudy breakthrough medication in 77 percent of patients with cancer. (1) Intranasal sufentanil is rapidly emerging as a treatment alternative in a number of other scenarios besides its role in achieving effective pain control in the emergency department. Intranasal administration is safe and provides rapid relief in patients with cancer who experience breakthrough cancer pain. The low prevalence of systemic side effects makes it an ideal option in patients with cancer.2)Read more...

Cite

APA

Kapoor, S., & MD (2012). Letter to the editor Intranasal sufentanil and its emerging clinical Applications: beyond its role in the emergency department. Journal of Opioid Management. https://doi.org/10.5055/10

Vancouver

Kapoor S, MD. Letter to the editor Intranasal sufentanil and its emerging clinical Applications: beyond its role in the emergency department. Journal of Opioid Management. 2012. doi:10.5055/10

BibTeX
@article{Kapoor2012,
  author = {Kapoor, Shailendra and MD},
  title = {Letter to the editor Intranasal sufentanil and its emerging clinical Applications: beyond its role in the emergency department},
  journal = {Journal of Opioid Management},
  year = {2012},
  doi = {10.5055/10}
}
Start for free →